Related Experiment Videos
A cholesterol-lowering gene maps to chromosome 13q.
H Knoblauch1, B Müller-Myhsok, A Busjahn
1Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine and Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
American Journal of Human Genetics
|January 13, 2000
Summary
Researchers identified a new gene influencing cholesterol levels by studying families with familial hypercholesterolemia (FH). This discovery offers potential for new treatments targeting lipid concentrations.
Area of Science:
- Human Genetics
- Molecular Biology
- Cardiovascular Research
Background:
- Familial hypercholesterolemia (FH) suggests a cholesterol-lowering gene, with affected individuals showing varied LDL levels.
- Previous studies hypothesized a gene influencing lipid metabolism based on FH family patterns.
Purpose of the Study:
- To identify and characterize a novel gene influencing lipid concentrations.
- To investigate the genetic basis of cholesterol regulation in humans.
Main Methods:
- Linkage analysis in FH families to identify chromosomal loci.
- Quantitative-trait-locus (QTL) analysis to verify genetic linkage for LDL levels.
- Twin studies (MZ and DZ) to confirm genetic variance in lipid concentrations.
- Identity-by-descent linkage analysis in dizygotic twins.
Main Results:
- A significant locus at 13q was identified, strongly linked to LDL levels (LOD scores >4).
- The 13q locus was confirmed as a QTL for LDL levels.
- Independent twin study data showed strong evidence for linkage at 13q with LDL, HDL, total cholesterol, and body-mass index.
Conclusions:
- The study provides strong evidence for a new gene influencing human lipid concentrations.
- The identified 13q locus is a significant QTL for multiple lipid parameters and BMI.
- This finding has implications for understanding and potentially treating dyslipidemias.